Intervacc AB
IVACC | FN
Overview
Corporate Details
- ISIN(s):
- SE0009607252 (+1 more)
- LEI:
- 549300OICIVZBBZRNZ64
- Country:
- Sweden
- Address:
- Västertorpsvägen 135B, 129 44 Hägersten
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Intervacc AB develops vaccines for animal health, focusing on infectious diseases in livestock. Their products promote sustainable agriculture.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-26 | Lennart Johansson | Other | Other | 813,474 | 691,452.90 SEK |
| 2025-02-21 | Lennart Johansson | Other | Other | 324,156 | 275,532.60 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV | |
|
Enorama Pharma AB | Sweden | ERMA | |
|
Enzymatica AB | Sweden | ENZY | |
|
EQL Pharma AB | Sweden | EQL |